FLXN

Flexion Therapeutics IncCIK 1419600 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for FLXN PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for FLXN

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Muzikant Adam	Chief Business Officer	11	$0	$56.6K	2021-11-19
Kwo Elizabeth	Director	6	$0	$0	2021-11-19
Layman Melissa	Chief Commercial Officer	11	$0	$86.3K	2021-11-19
Willwerth Christina	Chief Strategy Officer	25	$0	$98.9K	2021-11-19
Koppikar Utpal	Director	2	$0	$0	2021-11-19
Andrews William T.	Chief Medical Officer	4	$0	$0	2021-11-19
Levine Mark S.	SVP & General Counsel	23	$0	$110.5K	2021-11-19
Clayman Michael D.	President and CEO	91	$927.6K	$40.5K	2021-11-19
Lukatch Heath	Director	14	$0	$0	2021-11-19
Newtyn Management, LLC	10% Owner	1	$0	$0	2021-11-19
Stejbach Mark	Director	17	$46.9K	$0	2021-11-19
Wentworth Kerry	Chief Regulatory Officer	35	$0	$109.1K	2021-11-19
Canute Scott A	Director	20	$0	$0	2021-11-19
MAHAFFY PATRICK J	Director	22	$0	$0	2021-11-19
MERRIFIELD C ANN	Director	22	$137.5K	$0	2021-11-19
MILINAZZO ALAN	Director	22	$0	$0	2021-11-19
COLELLA SAMUEL D	Director, 10% Owner	56	$15.22M	$0	2021-11-19
DRISCOLL FREDERICK W	Chief Financial Officer	22	$47.6K	$736.6K	2021-11-19
Arkowitz David	Chief Financial Officer	22	$235.5K	$132.6K	2021-05-10
KELLEY SCOTT	Chief Medical Officer	17	$0	$83.7K	2021-03-01
Mahatme Sandesh	Director	9	$0	$0	2020-06-10
Bodick Neil	Chief Scientific Officer	60	$115.2K	$2.86M	2020-01-03
Deniz Yamo	Chief Medical Officer	7	$131.7K	$0	2017-09-05
Versant Development Fund III, L.P.	Director, 10% Owner	4	$10.00M	$0	2016-06-08
LUBASH BARBARA N	10% Owner	2	$10.00M	$0	2016-06-08
Novo A/S	10% Owner	7	$17.50M	$3.09M	2015-06-22
Sofinnova Partners SAS	10% Owner	6	$3.00M	$200.0K	2014-10-29
Schwab Andrew J.	Director, 10% Owner	5	$0	$0	2014-03-03
Tordjman Rafael	Director, 10% Owner	6	$3.00M	$0	2014-03-03
Bolzon Bradley J PhD	Director, 10% Owner	6	$4.00M	$0	2014-03-03
PFIZER INC	10% Owner	4	$0	$0	2014-02-18
Versant Venture Capital III, L.P.	10% Owner	12	$4.00M	$0	2014-02-18
5AM Ventures II LP	10% Owner	4	$0	$0	2014-02-18

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Clayman Michael D.	President and CEO	D To issuer deriv	2021-11-19	2021-11-19	136,530	—	$0	0	SEC↗
Clayman Michael D.	President and CEO	D To issuer deriv	2021-11-19	2021-11-19	200,000	—	$0	0	SEC↗
Clayman Michael D.	President and CEO	D To issuer deriv	2021-11-19	2021-11-19	110,000	—	$0	0	SEC↗
Clayman Michael D.	President and CEO	D To issuer deriv	2021-11-19	2021-11-19	155,000	—	$0	0	SEC↗
Clayman Michael D.	President and CEO	D To issuer deriv	2021-11-19	2021-11-19	106,100	—	$0	0	SEC↗
Clayman Michael D.	President and CEO	D To issuer deriv	2021-11-19	2021-11-19	185,000	—	$0	0	SEC↗
Clayman Michael D.	President and CEO	D To issuer deriv	2021-11-19	2021-11-19	290,000	—	$0	0	SEC↗
Clayman Michael D.	President and CEO	D To issuer deriv	2021-11-19	2021-11-19	116,667	—	$0	0	SEC↗
Clayman Michael D.	President and CEO	D To issuer deriv	2021-11-19	2021-11-19	175,000	—	$0	0	SEC↗
Andrews William T.	Chief Medical Officer	D To issuer deriv	2021-11-19	2021-11-19	205,500	—	$0	0	SEC↗
DRISCOLL FREDERICK W	Chief Financial Officer	D To issuer deriv	2021-11-19	2021-11-19	168,000	—	$0	0	SEC↗
Willwerth Christina	Chief Strategy Officer	D To issuer deriv	2021-11-19	2021-11-19	20,000	—	$0	0	SEC↗
Willwerth Christina	Chief Strategy Officer	D To issuer deriv	2021-11-19	2021-11-19	25,830	—	$0	0	SEC↗
Willwerth Christina	Chief Strategy Officer	D To issuer deriv	2021-11-19	2021-11-19	32,000	—	$0	0	SEC↗
Willwerth Christina	Chief Strategy Officer	D To issuer deriv	2021-11-19	2021-11-19	25,000	—	$0	0	SEC↗
Willwerth Christina	Chief Strategy Officer	D To issuer deriv	2021-11-19	2021-11-19	5,000	—	$0	0	SEC↗
Willwerth Christina	Chief Strategy Officer	D To issuer deriv	2021-11-19	2021-11-19	15,500	—	$0	0	SEC↗
Willwerth Christina	Chief Strategy Officer	D To issuer deriv	2021-11-19	2021-11-19	25,000	—	$0	0	SEC↗
Willwerth Christina	Chief Strategy Officer	D To issuer deriv	2021-11-19	2021-11-19	23,333	—	$0	0	SEC↗
Willwerth Christina	Chief Strategy Officer	D To issuer deriv	2021-11-19	2021-11-19	18,000	—	$0	0	SEC↗
Willwerth Christina	Chief Strategy Officer	D To issuer deriv	2021-11-19	2021-11-19	20,000	—	$0	0	SEC↗
Layman Melissa	Chief Commercial Officer	D To issuer deriv	2021-11-19	2021-11-19	20,100	—	$0	0	SEC↗
Layman Melissa	Chief Commercial Officer	D To issuer deriv	2021-11-19	2021-11-19	30,000	—	$0	0	SEC↗
Wentworth Kerry	Chief Regulatory Officer	D To issuer deriv	2021-11-19	2021-11-19	33,333	—	$0	0	SEC↗
Wentworth Kerry	Chief Regulatory Officer	D To issuer deriv	2021-11-19	2021-11-19	10,000	—	$0	0	SEC↗
Wentworth Kerry	Chief Regulatory Officer	D To issuer deriv	2021-11-19	2021-11-19	20,000	—	$0	0	SEC↗
Wentworth Kerry	Chief Regulatory Officer	D To issuer deriv	2021-11-19	2021-11-19	35,000	—	$0	0	SEC↗
Wentworth Kerry	Chief Regulatory Officer	D To issuer deriv	2021-11-19	2021-11-19	10,000	—	$0	0	SEC↗
Wentworth Kerry	Chief Regulatory Officer	D To issuer deriv	2021-11-19	2021-11-19	18,000	—	$0	0	SEC↗
Wentworth Kerry	Chief Regulatory Officer	D To issuer deriv	2021-11-19	2021-11-19	15,500	—	$0	0	SEC↗
Wentworth Kerry	Chief Regulatory Officer	D To issuer deriv	2021-11-19	2021-11-19	20,000	—	$0	0	SEC↗
Wentworth Kerry	Chief Regulatory Officer	D To issuer deriv	2021-11-19	2021-11-19	24,000	—	$0	0	SEC↗
Muzikant Adam	Chief Business Officer	D To issuer deriv	2021-11-19	2021-11-19	11,000	—	$0	0	SEC↗
Muzikant Adam	Chief Business Officer	D To issuer deriv	2021-11-19	2021-11-19	16,667	—	$0	0	SEC↗
Muzikant Adam	Chief Business Officer	D To issuer deriv	2021-11-19	2021-11-19	25,000	—	$0	0	SEC↗
Muzikant Adam	Chief Business Officer	D To issuer deriv	2021-11-19	2021-11-19	40,000	—	$0	0	SEC↗
Muzikant Adam	Chief Business Officer	D To issuer deriv	2021-11-19	2021-11-19	20,000	—	$0	0	SEC↗
Levine Mark S.	General Counsel	D To issuer deriv	2021-11-19	2021-11-19	18,000	—	$0	0	SEC↗
Levine Mark S.	General Counsel	D To issuer deriv	2021-11-19	2021-11-19	15,500	—	$0	0	SEC↗
Levine Mark S.	General Counsel	D To issuer deriv	2021-11-19	2021-11-19	20,000	—	$0	0	SEC↗
Levine Mark S.	General Counsel	D To issuer deriv	2021-11-19	2021-11-19	33,333	—	$0	0	SEC↗
Levine Mark S.	General Counsel	D To issuer deriv	2021-11-19	2021-11-19	125,000	—	$0	0	SEC↗
MAHAFFY PATRICK J	Director	D To issuer deriv	2021-11-19	2021-11-19	18,000	—	$0	0	SEC↗
MAHAFFY PATRICK J	Director	D To issuer deriv	2021-11-19	2021-11-19	12,500	—	$0	0	SEC↗
MAHAFFY PATRICK J	Director	D To issuer deriv	2021-11-19	2021-11-19	18,000	—	$0	0	SEC↗
MAHAFFY PATRICK J	Director	D To issuer deriv	2021-11-19	2021-11-19	18,000	—	$0	0	SEC↗
MAHAFFY PATRICK J	Director	D To issuer deriv	2021-11-19	2021-11-19	12,500	—	$0	0	SEC↗
MAHAFFY PATRICK J	Director	D To issuer deriv	2021-11-19	2021-11-19	18,000	—	$0	0	SEC↗
MAHAFFY PATRICK J	Director	D To issuer deriv	2021-11-19	2021-11-19	18,000	—	$0	0	SEC↗
MAHAFFY PATRICK J	Director	D To issuer deriv	2021-11-19	2021-11-19	18,000	—	$0	0	SEC↗
Canute Scott A	Director	D To issuer deriv	2021-11-19	2021-11-19	12,500	—	$0	0	SEC↗
Canute Scott A	Director	D To issuer deriv	2021-11-19	2021-11-19	7,000	—	$0	0	SEC↗
Canute Scott A	Director	D To issuer deriv	2021-11-19	2021-11-19	12,500	—	$0	0	SEC↗
Canute Scott A	Director	D To issuer deriv	2021-11-19	2021-11-19	12,500	—	$0	0	SEC↗
Canute Scott A	Director	D To issuer deriv	2021-11-19	2021-11-19	7,000	—	$0	0	SEC↗
Canute Scott A	Director	D To issuer deriv	2021-11-19	2021-11-19	12,500	—	$0	0	SEC↗
Canute Scott A	Director	D To issuer deriv	2021-11-19	2021-11-19	9,000	—	$0	0	SEC↗
Canute Scott A	Director	D To issuer deriv	2021-11-19	2021-11-19	18,000	—	$0	0	SEC↗
COLELLA SAMUEL D	Director	D To issuer deriv	2021-11-19	2021-11-19	9,000	—	$0	0	SEC↗
COLELLA SAMUEL D	Director	D To issuer deriv	2021-11-19	2021-11-19	12,500	—	$0	0	SEC↗
COLELLA SAMUEL D	Director	D To issuer deriv	2021-11-19	2021-11-19	12,500	—	$0	0	SEC↗
COLELLA SAMUEL D	Director	D To issuer deriv	2021-11-19	2021-11-19	12,500	—	$0	0	SEC↗
COLELLA SAMUEL D	Director	D To issuer deriv	2021-11-19	2021-11-19	12,500	—	$0	0	SEC↗
COLELLA SAMUEL D	Director	D To issuer deriv	2021-11-19	2021-11-19	9,000	—	$0	0	SEC↗
COLELLA SAMUEL D	Director	D To issuer deriv	2021-11-19	2021-11-19	7,000	—	$0	0	SEC↗
COLELLA SAMUEL D	Director	D To issuer deriv	2021-11-19	2021-11-19	7,000	—	$0	0	SEC↗
Koppikar Utpal	Director	D To issuer deriv	2021-11-19	2021-11-19	32,000	—	$0	0	SEC↗
Kwo Elizabeth	Director	D To issuer deriv	2021-11-19	2021-11-19	32,000	—	$0	0	SEC↗
Kwo Elizabeth	Director	D To issuer deriv	2021-11-19	2021-11-19	7,000	—	$0	0	SEC↗
Lukatch Heath	Director	D To issuer deriv	2021-11-19	2021-11-19	12,500	—	$0	0	SEC↗
Lukatch Heath	Director	D To issuer deriv	2021-11-19	2021-11-19	7,000	—	$0	0	SEC↗
Lukatch Heath	Director	D To issuer deriv	2021-11-19	2021-11-19	7,000	—	$0	0	SEC↗
Lukatch Heath	Director	D To issuer deriv	2021-11-19	2021-11-19	12,500	—	$0	0	SEC↗
Lukatch Heath	Director	D To issuer deriv	2021-11-19	2021-11-19	9,000	—	$0	0	SEC↗
MERRIFIELD C ANN	Director	D To issuer deriv	2021-11-19	2021-11-19	12,500	—	$0	0	SEC↗
MERRIFIELD C ANN	Director	D To issuer deriv	2021-11-19	2021-11-19	7,000	—	$0	0	SEC↗
MERRIFIELD C ANN	Director	D To issuer deriv	2021-11-19	2021-11-19	12,500	—	$0	0	SEC↗
MERRIFIELD C ANN	Director	D To issuer deriv	2021-11-19	2021-11-19	12,500	—	$0	0	SEC↗
MERRIFIELD C ANN	Director	D To issuer deriv	2021-11-19	2021-11-19	7,000	—	$0	0	SEC↗
MERRIFIELD C ANN	Director	D To issuer deriv	2021-11-19	2021-11-19	12,500	—	$0	0	SEC↗
MERRIFIELD C ANN	Director	D To issuer deriv	2021-11-19	2021-11-19	9,000	—	$0	0	SEC↗
MERRIFIELD C ANN	Director	D To issuer deriv	2021-11-19	2021-11-19	18,000	—	$0	0	SEC↗
MILINAZZO ALAN	Director	D To issuer deriv	2021-11-19	2021-11-19	12,500	—	$0	0	SEC↗
MILINAZZO ALAN	Director	D To issuer deriv	2021-11-19	2021-11-19	7,000	—	$0	0	SEC↗
MILINAZZO ALAN	Director	D To issuer deriv	2021-11-19	2021-11-19	12,500	—	$0	0	SEC↗
MILINAZZO ALAN	Director	D To issuer deriv	2021-11-19	2021-11-19	12,500	—	$0	0	SEC↗
MILINAZZO ALAN	Director	D To issuer deriv	2021-11-19	2021-11-19	7,000	—	$0	0	SEC↗
MILINAZZO ALAN	Director	D To issuer deriv	2021-11-19	2021-11-19	12,500	—	$0	0	SEC↗
MILINAZZO ALAN	Director	D To issuer deriv	2021-11-19	2021-11-19	9,000	—	$0	0	SEC↗
MILINAZZO ALAN	Director	D To issuer deriv	2021-11-19	2021-11-19	9,000	—	$0	0	SEC↗
Stejbach Mark	Director	D To issuer deriv	2021-11-19	2021-11-19	12,500	—	$0	0	SEC↗
Stejbach Mark	Director	D To issuer deriv	2021-11-19	2021-11-19	7,000	—	$0	0	SEC↗
Stejbach Mark	Director	D To issuer deriv	2021-11-19	2021-11-19	12,500	—	$0	0	SEC↗
Stejbach Mark	Director	D To issuer deriv	2021-11-19	2021-11-19	7,000	—	$0	0	SEC↗
Stejbach Mark	Director	D To issuer deriv	2021-11-19	2021-11-19	12,500	—	$0	0	SEC↗
Stejbach Mark	Director	D To issuer deriv	2021-11-19	2021-11-19	25,000	—	$0	0	SEC↗
Clayman Michael D.	President and CEO	D To issuer	2021-11-19	2021-11-19	388,683	$8.50	$3.30M	0	SEC↗
Clayman Michael D.	President and CEO	D To issuer	2021-11-19	2021-11-19	24,600	$8.50	$209.1K	0	SEC↗
Clayman Michael D.	President and CEO	D To issuer	2021-11-19	2021-11-19	373,769	$8.50	$3.18M	0	SEC↗
Clayman Michael D.	President and CEO	D To issuer	2021-11-19	2021-11-19	335,498	$8.50	$2.85M	0	SEC↗
Andrews William T.	Chief Medical Officer	D To issuer	2021-11-19	2021-11-19	34,250	$8.50	$291.1K	0	SEC↗
DRISCOLL FREDERICK W	Chief Financial Officer	D To issuer	2021-11-19	2021-11-19	30,680	$8.50	$260.8K	0	SEC↗
Willwerth Christina	Chief Strategy Officer	D To issuer	2021-11-19	2021-11-19	141,241	$8.50	$1.20M	0	SEC↗
Layman Melissa	Chief Commercial Officer	D To issuer	2021-11-19	2021-11-19	103,956	$8.50	$883.6K	0	SEC↗
Wentworth Kerry	Chief Regulatory Officer	D To issuer	2021-11-19	2021-11-19	140,843	$8.50	$1.20M	0	SEC↗
Wentworth Kerry	Chief Regulatory Officer	D To issuer	2021-11-19	2021-11-19	6,000	$8.50	$51.0K	0	SEC↗
Muzikant Adam	Chief Business Officer	D To issuer	2021-11-19	2021-11-19	103,666	$8.50	$881.2K	0	SEC↗
Levine Mark S.	General Counsel	D To issuer	2021-11-19	2021-11-19	133,486	$8.50	$1.13M	0	SEC↗
MAHAFFY PATRICK J	Director	D To issuer	2021-11-19	2021-11-19	39,824	$8.50	$338.5K	0	SEC↗
Canute Scott A	Director	D To issuer	2021-11-19	2021-11-19	9,000	$8.50	$76.5K	0	SEC↗
COLELLA SAMUEL D	Director	D To issuer	2021-11-19	2021-11-19	994,129	$8.50	$8.45M	0	SEC↗
COLELLA SAMUEL D	Director	D To issuer	2021-11-19	2021-11-19	5,000	$8.50	$42.5K	0	SEC↗
COLELLA SAMUEL D	Director	D To issuer	2021-11-19	2021-11-19	72,035	$8.50	$612.3K	0	SEC↗
COLELLA SAMUEL D	Director	D To issuer	2021-11-19	2021-11-19	5,871	$8.50	$49.9K	0	SEC↗
COLELLA SAMUEL D	Director	D To issuer	2021-11-19	2021-11-19	388,683	$8.50	$3.30M	0	SEC↗
COLELLA SAMUEL D	Director	D To issuer	2021-11-19	2021-11-19	943	$8.50	$8.0K	0	SEC↗
COLELLA SAMUEL D	Director	D To issuer	2021-11-19	2021-11-19	19,653	$8.50	$167.1K	0	SEC↗
COLELLA SAMUEL D	Director	D To issuer	2021-11-19	2021-11-19	250	$8.50	$2.1K	0	SEC↗
COLELLA SAMUEL D	Director	D To issuer	2021-11-19	2021-11-19	1,000	$8.50	$8.5K	0	SEC↗
COLELLA SAMUEL D	Director	D To issuer	2021-11-19	2021-11-19	9,000	$8.50	$76.5K	0	SEC↗
Kwo Elizabeth	Director	D To issuer	2021-11-19	2021-11-19	4,500	$8.50	$38.3K	0	SEC↗
Lukatch Heath	Director	D To issuer	2021-11-19	2021-11-19	9,000	$8.50	$76.5K	0	SEC↗
MERRIFIELD C ANN	Director	D To issuer	2021-11-19	2021-11-19	19,000	$8.50	$161.5K	0	SEC↗
MILINAZZO ALAN	Director	D To issuer	2021-11-19	2021-11-19	27,450	$8.50	$233.3K	0	SEC↗
Stejbach Mark	Director	D To issuer	2021-11-19	2021-11-19	12,631	$8.50	$107.4K	0	SEC↗
Newtyn Management, LLC	10% Owner	U Tender	2021-11-19	2021-11-23	5,900,000	—	$0	0	SEC↗
Andrews William T.	Chief Medical Officer	A Award deriv	2021-08-02	2021-08-04	205,500	—	$0	205,500	SEC↗
Andrews William T.	Chief Medical Officer	A Award	2021-08-02	2021-08-04	34,250	—	$0	34,250	SEC↗
Clayman Michael D.	President and CEO	F Tax w/h	2021-07-19	2021-07-20	13,859	—	$0	334,981	SEC↗
Levine Mark S.	General Counsel	S Sale	2021-07-19	2021-07-20	3,945	$6.45	$25.4K	133,486	SEC↗
Muzikant Adam	Chief Business Officer	S Sale	2021-07-19	2021-07-20	1,870	$6.45	$12.1K	103,666	SEC↗
Wentworth Kerry	Chief Regulatory Officer	S Sale	2021-07-19	2021-07-20	3,944	$6.45	$25.4K	140,362	SEC↗
Willwerth Christina	Chief Strategy Officer	S Sale	2021-07-19	2021-07-20	3,945	$6.45	$25.4K	141,241	SEC↗
Koppikar Utpal	Director	A Award deriv	2021-07-09	2021-07-12	32,000	—	$0	32,000	SEC↗
MILINAZZO ALAN	Director	A Award deriv	2021-06-24	2021-06-28	7,000	—	$0	7,000	SEC↗
MAHAFFY PATRICK J	Director	A Award deriv	2021-06-24	2021-06-28	12,500	—	$0	12,500	SEC↗
Lukatch Heath	Director	A Award deriv	2021-06-24	2021-06-28	7,000	—	$0	7,000	SEC↗
Stejbach Mark	Director	A Award deriv	2021-06-24	2021-06-28	7,000	—	$0	7,000	SEC↗
COLELLA SAMUEL D	Director	A Award deriv	2021-06-24	2021-06-28	7,000	—	$0	7,000	SEC↗
Canute Scott A	Director	A Award deriv	2021-06-24	2021-06-28	7,000	—	$0	7,000	SEC↗
MERRIFIELD C ANN	Director	A Award deriv	2021-06-24	2021-06-28	7,000	—	$0	7,000	SEC↗
Kwo Elizabeth	Director	A Award deriv	2021-06-24	2021-06-28	7,000	—	$0	7,000	SEC↗
MILINAZZO ALAN	Director	A Award	2021-06-24	2021-06-28	4,500	—	$0	27,450	SEC↗
MAHAFFY PATRICK J	Director	A Award	2021-06-24	2021-06-28	4,500	—	$0	39,824	SEC↗
Lukatch Heath	Director	A Award	2021-06-24	2021-06-28	4,500	—	$0	9,000	SEC↗
Stejbach Mark	Director	A Award	2021-06-24	2021-06-28	4,500	—	$0	12,631	SEC↗
COLELLA SAMUEL D	Director	A Award	2021-06-24	2021-06-28	4,500	—	$0	11,198	SEC↗
Canute Scott A	Director	A Award	2021-06-24	2021-06-28	4,500	—	$0	9,000	SEC↗
MERRIFIELD C ANN	Director	A Award	2021-06-24	2021-06-28	4,500	—	$0	19,000	SEC↗
Kwo Elizabeth	Director	A Award	2021-06-24	2021-06-28	4,500	—	$0	4,500	SEC↗
Clayman Michael D.	President and CEO	A Award	2021-06-21	2021-06-28	1,700	$7.78	$13.2K	348,840	SEC↗
Wentworth Kerry	Chief Regulatory Officer	A Award	2021-06-21	2021-06-28	539	$7.78	$4.2K	144,306	SEC↗
Muzikant Adam	Chief Business Officer	A Award	2021-06-21	2021-06-28	2,081	$7.78	$16.2K	105,536	SEC↗
DRISCOLL FREDERICK W	Chief Financial Officer	A Award deriv	2021-06-01	2021-06-03	168,000	—	$0	168,000	SEC↗
DRISCOLL FREDERICK W	Chief Financial Officer	A Award	2021-06-01	2021-06-03	28,000	—	$0	30,680	SEC↗
Arkowitz David	Chief Financial Officer	S Sale	2021-05-10	2021-05-12	2,229	$7.23	$16.1K	220,719	SEC↗
Layman Melissa	Chief Commercial Officer	S Sale	2021-03-15	2021-03-16	4,520	$11.80	$53.3K	103,956	SEC↗
Clayman Michael D.	President and CEO	A Award deriv	2021-03-01	2021-03-03	159,150	—	$0	159,150	SEC↗
Layman Melissa	Chief Commercial Officer	A Award deriv	2021-03-01	2021-03-03	30,150	—	$0	30,150	SEC↗
Arkowitz David	Chief Financial Officer	A Award deriv	2021-03-01	2021-03-03	20,000	—	$0	20,000	SEC↗
KELLEY SCOTT	Chief Medical Officer	A Award deriv	2021-03-01	2021-03-03	20,000	—	$0	20,000	SEC↗
Levine Mark S.	General Counsel	A Award deriv	2021-03-01	2021-03-03	20,000	—	$0	20,000	SEC↗
Willwerth Christina	Chief Strategy Officer	A Award deriv	2021-03-01	2021-03-03	20,000	—	$0	20,000	SEC↗
Wentworth Kerry	Chief Regulatory Officer	A Award deriv	2021-03-01	2021-03-03	20,000	—	$0	20,000	SEC↗
Muzikant Adam	Chief Business Officer	A Award deriv	2021-03-01	2021-03-03	20,000	—	$0	20,000	SEC↗
Clayman Michael D.	President and CEO	A Award	2021-03-01	2021-03-03	106,100	—	$0	373,001	SEC↗
Layman Melissa	Chief Commercial Officer	A Award	2021-03-01	2021-03-03	20,100	—	$0	108,476	SEC↗
Arkowitz David	Chief Financial Officer	A Award	2021-03-01	2021-03-03	30,000	—	$0	181,048	SEC↗
Arkowitz David	Chief Financial Officer	A Award	2021-03-01	2021-03-03	41,900	—	$0	222,948	SEC↗
KELLEY SCOTT	Chief Medical Officer	A Award	2021-03-01	2021-03-03	30,000	—	$0	143,549	SEC↗
Levine Mark S.	General Counsel	A Award	2021-03-01	2021-03-03	30,000	—	$0	137,431	SEC↗
Willwerth Christina	Chief Strategy Officer	A Award	2021-03-01	2021-03-03	30,000	—	$0	145,186	SEC↗
Wentworth Kerry	Chief Regulatory Officer	A Award	2021-03-01	2021-03-03	30,000	—	$0	143,767	SEC↗
Muzikant Adam	Chief Business Officer	A Award	2021-03-01	2021-03-03	30,000	—	$0	103,455	SEC↗
Clayman Michael D.	President and CEO	G Gift	2021-02-01	2021-03-23	21,099	—	$0	347,140	SEC↗
Clayman Michael D.	President and CEO	F Tax w/h	2021-01-28	2021-01-29	8,776	$12.37	$108.6K	266,901	SEC↗
Layman Melissa	Chief Commercial Officer	S Sale	2021-01-28	2021-01-29	2,624	$12.55	$32.9K	88,376	SEC↗
Clayman Michael D.	President and CEO	A Award	2021-01-27	2021-01-29	119,500	—	$0	275,677	SEC↗
Layman Melissa	Chief Commercial Officer	A Award	2021-01-27	2021-01-29	30,000	—	$0	91,000	SEC↗
COLELLA SAMUEL D	Director	J Other	2021-01-15	2021-01-20	19,653	—	$0	19,653	SEC↗
COLELLA SAMUEL D	Director	J Other	2021-01-15	2021-01-20	648,266	—	$0	648,266	SEC↗
COLELLA SAMUEL D	Director	J Other	2021-01-15	2021-01-20	2,517,541	—	$0	994,129	SEC↗
COLELLA SAMUEL D	Director	J Other	2021-01-15	2021-01-20	943	—	$0	943	SEC↗
COLELLA SAMUEL D	Director	J Other	2021-01-15	2021-01-20	2,198	—	$0	47,531	SEC↗
COLELLA SAMUEL D	Director	J Other	2021-01-15	2021-01-20	14,868	—	$0	5,871	SEC↗
COLELLA SAMUEL D	Director	J Other	2021-01-15	2021-01-20	648,266	—	$0	0	SEC↗
COLELLA SAMUEL D	Director	J Other	2021-01-15	2021-03-12	2,198	—	$0	69,837	SEC↗
Clayman Michael D.	President and CEO	G Gift	2021-01-08	2021-03-23	4,762	—	$0	368,239	SEC↗
Clayman Michael D.	President and CEO	F Tax w/h	2021-01-05	2021-01-07	2,530	—	$0	156,177	SEC↗
Arkowitz David	Chief Financial Officer	S Sale	2021-01-05	2021-01-07	6,073	$11.13	$67.6K	151,048	SEC↗
Levine Mark S.	General Counsel	S Sale	2021-01-05	2021-01-07	6,829	$11.13	$76.0K	107,431	SEC↗
Willwerth Christina	Chief Strategy Officer	S Sale	2021-01-05	2021-01-07	6,602	$11.13	$73.5K	115,186	SEC↗
Wentworth Kerry	Chief Regulatory Officer	S Sale	2021-01-05	2021-01-07	6,829	$11.13	$76.0K	113,767	SEC↗
KELLEY SCOTT	Chief Medical Officer	S Sale	2021-01-05	2021-01-07	6,829	$11.13	$76.0K	113,549	SEC↗
Muzikant Adam	Chief Business Officer	S Sale	2021-01-05	2021-01-07	4,005	$11.13	$44.6K	73,455	SEC↗
Kwo Elizabeth	Director	A Award deriv	2020-08-18	2020-08-20	32,000	—	$0	32,000	SEC↗
Wentworth Kerry	Chief Regulatory Officer	A Award	2020-07-16	2020-07-20	38,750	—	$0	120,180	SEC↗
Levine Mark S.	General Counsel	A Award	2020-07-16	2020-07-20	38,750	—	$0	114,260	SEC↗
Clayman Michael D.	President and CEO	A Award	2020-07-16	2020-07-20	93,750	—	$0	160,010	SEC↗
Willwerth Christina	Chief Strategy Officer	A Award	2020-07-16	2020-07-20	38,750	—	$0	121,788	SEC↗
KELLEY SCOTT	Chief Medical Officer	A Award	2020-07-16	2020-07-20	38,750	—	$0	119,710	SEC↗
Arkowitz David	Chief Financial Officer	A Award	2020-07-16	2020-07-20	38,750	—	$0	157,121	SEC↗
MILINAZZO ALAN	Director	M Exercise deriv	2020-07-09	2020-07-10	18,450	—	$0	0	SEC↗
MILINAZZO ALAN	Director	M Exercise	2020-07-09	2020-07-10	18,450	$2.20	$40.6K	22,950	SEC↗
Clayman Michael D.	President and CEO	G Gift	2020-07-08	2021-01-07	1,303	—	$0	158,707	SEC↗
Wentworth Kerry	Chief Regulatory Officer	A Award	2020-06-22	2020-06-24	369	$10.83	$4.0K	81,430	SEC↗
Levine Mark S.	General Counsel	A Award	2020-06-22	2020-06-24	1,023	$10.83	$11.1K	75,510	SEC↗
KELLEY SCOTT	Chief Medical Officer	A Award	2020-06-22	2020-06-24	595	$10.83	$6.4K	80,960	SEC↗
Clayman Michael D.	President and CEO	A Award	2020-06-22	2020-06-24	1,303	$10.83	$14.1K	66,260	SEC↗
Arkowitz David	Chief Financial Officer	A Award	2020-06-22	2020-06-24	1,303	$10.83	$14.1K	118,371	SEC↗
Canute Scott A	Director	A Award deriv	2020-06-10	2020-06-12	7,000	—	$0	7,000	SEC↗
COLELLA SAMUEL D	Director, 10% Owner	A Award deriv	2020-06-10	2020-06-12	7,000	—	$0	7,000	SEC↗
Lukatch Heath	Director	A Award deriv	2020-06-10	2020-06-12	7,000	—	$0	7,000	SEC↗
Mahatme Sandesh	Director	A Award deriv	2020-06-10	2020-06-12	7,000	—	$0	7,000	SEC↗
MERRIFIELD C ANN	Director	A Award deriv	2020-06-10	2020-06-12	7,000	—	$0	7,000	SEC↗
MILINAZZO ALAN	Director	A Award deriv	2020-06-10	2020-06-12	7,000	—	$0	7,000	SEC↗
MAHAFFY PATRICK J	Director	A Award deriv	2020-06-10	2020-06-12	12,500	—	$0	12,500	SEC↗
Stejbach Mark	Director	A Award deriv	2020-06-10	2020-06-12	7,000	—	$0	7,000	SEC↗
Canute Scott A	Director	A Award	2020-06-10	2020-06-12	4,500	—	$0	4,500	SEC↗
COLELLA SAMUEL D	Director, 10% Owner	A Award	2020-06-10	2020-06-12	4,500	—	$0	30,004	SEC↗
Lukatch Heath	Director	A Award	2020-06-10	2020-06-12	4,500	—	$0	4,500	SEC↗
Mahatme Sandesh	Director	A Award	2020-06-10	2020-06-12	4,500	—	$0	4,500	SEC↗
MERRIFIELD C ANN	Director	A Award	2020-06-10	2020-06-12	4,500	—	$0	14,500	SEC↗
MILINAZZO ALAN	Director	A Award	2020-06-10	2020-06-12	4,500	—	$0	4,500	SEC↗
MAHAFFY PATRICK J	Director	A Award	2020-06-10	2020-06-12	4,500	—	$0	35,324	SEC↗
Stejbach Mark	Director	A Award	2020-06-10	2020-06-12	4,500	—	$0	6,551	SEC↗
Willwerth Christina	Chief Strategy Officer	J Other	2020-06-09	2020-06-24	435	—	$0	83,038	SEC↗
Clayman Michael D.	President and CEO	P Buy	2020-05-26	2020-05-27	10,256	$9.75	$100.0K	346,605	SEC↗
Stejbach Mark	Director	P Buy	2020-05-26	2020-05-27	2,051	$9.75	$20.0K	2,051	SEC↗
Arkowitz David	Chief Financial Officer	S Sale	2020-05-07	2020-05-11	2,413	$10.88	$26.3K	117,068	SEC↗
Layman Melissa	Chief Commercial Officer	A Award deriv	2020-04-01	2020-04-03	30,000	—	$0	30,000	SEC↗
Layman Melissa	Chief Commercial Officer	A Award deriv	2020-04-01	2020-04-03	30,000	—	$0	30,000	SEC↗
Layman Melissa	Chief Commercial Officer	A Award	2020-04-01	2020-04-03	61,000	—	$0	61,000	SEC↗
Clayman Michael D.	President and CEO	A Award deriv	2020-03-02	2020-03-03	175,000	—	$0	175,000	SEC↗
Clayman Michael D.	President and CEO	A Award deriv	2020-03-02	2020-03-03	185,000	—	$0	185,000	SEC↗
KELLEY SCOTT	Chief Medical Officer	A Award deriv	2020-03-02	2020-03-03	15,500	—	$0	15,500	SEC↗
Arkowitz David	Chief Financial Officer	A Award deriv	2020-03-02	2020-03-03	15,500	—	$0	15,500	SEC↗
Levine Mark S.	General Counsel	A Award deriv	2020-03-02	2020-03-03	15,500	—	$0	15,500	SEC↗
Wentworth Kerry	Chief Regulatory Officer	A Award deriv	2020-03-02	2020-03-03	15,500	—	$0	15,500	SEC↗
Willwerth Christina	Chief Strategy Officer	A Award deriv	2020-03-02	2020-03-03	15,500	—	$0	15,500	SEC↗
KELLEY SCOTT	Chief Medical Officer	A Award	2020-03-02	2020-03-03	31,000	—	$0	80,365	SEC↗
Arkowitz David	Chief Financial Officer	A Award	2020-03-02	2020-03-03	31,000	—	$0	119,481	SEC↗
Levine Mark S.	General Counsel	A Award	2020-03-02	2020-03-03	31,000	—	$0	74,487	SEC↗
Wentworth Kerry	Chief Regulatory Officer	A Award	2020-03-02	2020-03-03	31,000	—	$0	81,061	SEC↗
Willwerth Christina	Chief Strategy Officer	A Award	2020-03-02	2020-03-03	31,000	—	$0	83,473	SEC↗
Clayman Michael D.	President and CEO	G Gift	2020-01-07	2020-01-07	5,457	—	$0	336,349	SEC↗
Clayman Michael D.	President and CEO	G Gift	2020-01-07	2020-01-07	5,457	—	$0	64,957	SEC↗
Bodick Neil	Chief Scientific Officer	S Sale	2020-01-03	2020-01-07	3,851	—	$0	100,153	SEC↗
Arkowitz David	Chief Financial Officer	S Sale	2020-01-03	2020-01-07	3,095	—	$0	88,481	SEC↗
Wentworth Kerry	Chief Regulatory Officer	S Sale	2020-01-03	2020-01-07	3,724	—	$0	50,061	SEC↗
Levine Mark S.	General Counsel	S Sale	2020-01-03	2020-01-07	3,724	—	$0	43,487	SEC↗
KELLEY SCOTT	Chief Medical Officer	S Sale	2020-01-03	2020-01-07	3,724	—	$0	49,365	SEC↗
Willwerth Christina	Chief Strategy Officer	S Sale	2020-01-03	2020-01-07	3,533	—	$0	52,473	SEC↗
Clayman Michael D.	President and CEO	F Tax w/h	2020-01-03	2020-01-07	2,494	—	$0	70,414	SEC↗
Clayman Michael D.	President and CEO	G Gift	2019-10-09	2020-01-07	10,398	—	$0	72,249	SEC↗
Clayman Michael D.	President and CEO	G Gift	2019-10-09	2020-01-07	10,398	—	$0	330,892	SEC↗
Bodick Neil	Chief Scientific Officer	F Tax w/h	2019-10-07	2019-10-08	1,346	$13.98	$18.8K	104,004	SEC↗
KELLEY SCOTT	Chief Medical Officer	F Tax w/h	2019-10-07	2019-10-08	334	$13.98	$4.7K	53,089	SEC↗
Clayman Michael D.	President and CEO	F Tax w/h	2019-10-07	2019-10-08	4,402	$13.98	$61.5K	82,647	SEC↗
Wentworth Kerry	Chief Regulatory Officer	F Tax w/h	2019-10-07	2019-10-08	1,002	$13.98	$14.0K	53,394	SEC↗
Willwerth Christina	Chief Strategy Officer	F Tax w/h	2019-10-07	2019-10-08	1,002	$13.98	$14.0K	66,167	SEC↗
Bodick Neil	Chief Scientific Officer	M Exercise deriv	2019-10-06	2019-10-08	4,568	—	$0	0	SEC↗
Clayman Michael D.	President and CEO	M Exercise deriv	2019-10-06	2019-10-08	14,800	—	$0	0	SEC↗
Wentworth Kerry	Chief Regulatory Officer	M Exercise deriv	2019-10-06	2019-10-08	3,400	—	$0	0	SEC↗
Bodick Neil	Chief Scientific Officer	M Exercise	2019-10-06	2019-10-08	4,568	—	$0	105,350	SEC↗
Clayman Michael D.	President and CEO	M Exercise	2019-10-06	2019-10-08	14,800	—	$0	87,049	SEC↗
Wentworth Kerry	Chief Regulatory Officer	M Exercise	2019-10-06	2019-10-08	3,400	—	$0	54,396	SEC↗
MAHAFFY PATRICK J	Director	M Exercise deriv	2019-08-29	2019-08-29	30,824	—	$0	0	SEC↗
MAHAFFY PATRICK J	Director	M Exercise	2019-08-29	2019-08-29	30,824	$0.16	$4.9K	30,824	SEC↗
Willwerth Christina	Chief Strategy Officer	M Exercise deriv	2019-08-13	2019-08-14	8,750	—	$0	0	SEC↗
Willwerth Christina	Chief Strategy Officer	M Exercise	2019-08-13	2019-08-14	8,750	$0.16	$1.4K	67,169	SEC↗
Clayman Michael D.	President and CEO	P Buy	2019-08-08	2019-08-08	2,317	$10.85	$25.1K	72,249	SEC↗
COLELLA SAMUEL D	Director, 10% Owner	P Buy	2019-08-08	2019-08-09	2,000	$10.74	$21.5K	45,333	SEC↗
Clayman Michael D.	President and CEO	G Gift	2019-06-24	2019-06-24	1,492	—	$0	320,494	SEC↗
Clayman Michael D.	President and CEO	G Gift	2019-06-24	2019-06-24	1,492	—	$0	69,932	SEC↗
Arkowitz David	Chief Financial Officer	A Award	2019-06-21	2019-06-24	2,152	$9.81	$21.1K	91,576	SEC↗
KELLEY SCOTT	Chief Medical Officer	A Award	2019-06-21	2019-06-24	2,152	$9.81	$21.1K	53,423	SEC↗
Wentworth Kerry	Chief Regulatory Officer	A Award	2019-06-21	2019-06-24	389	$9.81	$3.8K	50,996	SEC↗
Levine Mark S.	General Counsel	A Award	2019-06-21	2019-06-24	1,213	$9.81	$11.9K	46,273	SEC↗
Clayman Michael D.	President and CEO	A Award	2019-06-21	2019-06-24	1,492	$9.81	$14.6K	71,424	SEC↗
MAHAFFY PATRICK J	Director	A Award deriv	2019-06-19	2019-06-21	18,000	—	$0	18,000	SEC↗
Canute Scott A	Director	A Award deriv	2019-06-19	2019-06-21	12,500	—	$0	12,500	SEC↗
COLELLA SAMUEL D	Director, 10% Owner	A Award deriv	2019-06-19	2019-06-21	12,500	—	$0	12,500	SEC↗
Mahatme Sandesh	Director	A Award deriv	2019-06-19	2019-06-21	12,500	—	$0	12,500	SEC↗
MERRIFIELD C ANN	Director	A Award deriv	2019-06-19	2019-06-21	12,500	—	$0	12,500	SEC↗
MILINAZZO ALAN	Director	A Award deriv	2019-06-19	2019-06-21	12,500	—	$0	12,500	SEC↗
Stejbach Mark	Director	A Award deriv	2019-06-19	2019-06-21	12,500	—	$0	12,500	SEC↗
Arkowitz David	Chief Financial Officer	P Buy	2019-05-31	2019-06-03	2,500	$11.05	$27.6K	89,424	SEC↗
MERRIFIELD C ANN	Director	P Buy	2019-05-23	2019-05-24	8,000	$12.64	$101.1K	10,000	SEC↗
Arkowitz David	Chief Financial Officer	P Buy	2019-05-13	2019-05-15	4,000	$11.99	$48.0K	86,924	SEC↗
Clayman Michael D.	President and CEO	P Buy	2019-05-10	2019-05-13	4,012	$12.48	$50.1K	74,868	SEC↗
Arkowitz David	Chief Financial Officer	S Sale	2019-05-08	2019-05-09	2,248	$10.06	$22.6K	82,924	SEC↗
Clayman Michael D.	President and CEO	P Buy	2019-03-12	2019-03-13	4,046	$12.36	$50.0K	70,856	SEC↗
Clayman Michael D.	President and CEO	A Award deriv	2019-03-01	2019-03-05	360,000	—	$0	360,000	SEC↗
Bodick Neil	Chief Scientific Officer	A Award deriv	2019-03-01	2019-03-05	18,000	—	$0	18,000	SEC↗
Arkowitz David	Chief Financial Officer	A Award deriv	2019-03-01	2019-03-05	18,000	—	$0	18,000	SEC↗
Levine Mark S.	General Counsel	A Award deriv	2019-03-01	2019-03-05	18,000	—	$0	18,000	SEC↗
Willwerth Christina	Chief Strategy Officer	A Award deriv	2019-03-01	2019-03-05	18,000	—	$0	18,000	SEC↗
KELLEY SCOTT	Chief Medical Officer	A Award deriv	2019-03-01	2019-03-05	18,000	—	$0	18,000	SEC↗
Wentworth Kerry	Chief Regulatory Officer	A Award deriv	2019-03-01	2019-03-05	18,000	—	$0	18,000	SEC↗